Proteintech

PSMB5 Polyclonal Antibody

View all (6) PSMB5 antibodies

Questions & Answers

Questions & Answers

Product Image Gallery

PSMB5 Antibody in Immunocytochemistry (ICC/IF) — Immunofluorescent analysis of HepG2 cells using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 and Alexa Fluor 488-conjugated AffiniPure Goat Anti-Rabbit IGG (H+L).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human hepatocirrhosis using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 10x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human hepatocirrhosis using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 40x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human hepatocirrhosis using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 10x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human hepatocirrhosis using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 40x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human hepatocirrhosis using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 10x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human hepatocirrhosis using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 40x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human breast cancer using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 40x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human breast cancer using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 10x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human breast cancer using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 40x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human breast cancer using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 10x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human breast cancer using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 40x lens).

PSMB5 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry of paraffin-embedded human breast cancer using 19178-1-AP (PSMB5 antibody) at dilution of 1:50 (under 10x lens).

PSMB5 Antibody in Western Blot (WB) — Jurkat cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — Jurkat cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — Jurkat cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — Jurkat cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — Jurkat cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — Jurkat cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — Jurkat cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — Jurkat cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — Jurkat cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — HeLa cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — L02 cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — HeLa cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — HeLa cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — L02 cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — L02 cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — L02 cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

PSMB5 Antibody in Western Blot (WB) — L02 cells were subjected to SDS PAGE followed by western blot with 19178-1-AP (PSMB5 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

Product Details

Applications

Tested Dilution

Publications

Western Blot (WB)

1:500-1:2,000

View 1 publication 1 publication

Immunohistochemistry (Paraffin) (IHC (P))

1:20-1:200

-

Immunocytochemistry (ICC/IF)

1:20-1:200

-

Product Specifications

Species Reactivity

Human, Mouse, Rat

Published species

Human

Host/Isotype

Rabbit / IgG

Class

Polyclonal

Type

Antibody

Immunogen

PSMB5 Fusion Protein Ag5828

Conjugate

Unconjugated

Form

Liquid

Concentration

0.22 mg/mL

Purification

Antigen affinity chromatography

Storage buffer

PBS, pH 7.3, with 50% glycerol

Contains

0.02% sodium azide

Storage conditions

-20°C

Target Information

Cyclic nucleotide phosphodiesterases.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Bioinformatics

Protein Aliases: Macropain epsilon chain; MGC118075; Multicatalytic endopeptidase complex epsilon chain; proteasome (prosome, macropain) subunit, beta type, 5; proteasome beta 5 subunit; proteasome beta type subunit 5; proteasome catalytic subunit 3; Proteasome chain 6; Proteasome epsilon chain; Proteasome subunit beta type-5; Proteasome subunit MB1; Proteasome subunit X; proteasome subunit, beta type, 5; PSX large multifunctional protease X; testicular tissue protein Li 153

Gene Aliases: LMPX; MB1; PSMB5; X

UniProt ID: (Human) P28074, (Rat) P28075, (Mouse) O55234

Entrez Gene ID: (Human) 5693, (Rat) 29425, (Mouse) 19173

Molecular Function: protease

MAPK cascade protein polyubiquitination stimulatory C-type lectin receptor signaling pathway antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent proteolysis regulation of cellular amino acid metabolic process response to oxidative stress viral process anaphase-promoting complex-dependent catabolic process tumor necrosis factor-mediated signaling pathway NIK/NF-kappaB signaling Fc-epsilon receptor signaling pathway proteasome-mediated ubiquitin-dependent protein catabolic process regulation of mRNA stability T cell receptor signaling pathway negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition Wnt signaling pathway, planar cell polarity pathway negative regulation of canonical Wnt signaling pathway positive regulation of canonical Wnt signaling pathway proteolysis involved in cellular protein catabolic process proteasomal ubiquitin-independent protein catabolic process

Process(es)

threonine-type endopeptidase activity protein binding peptidase activity endopeptidase activity hydrolase activity